News

Febbraio 2023
Association of 5α-reductase inhibitors with dementia, depression, and suicide
Gennaio 2023
Buprenorphine versus methadone for opioid use disorder in pregnancy
Gennaio 2023
GLP-1 receptor agonist-associated tumor adverse events: a real-world study from 2004 to 2021 based on FAERS. Front Pharmacol 2022; DOI:10.3389/fphar.2022.925377
Gennaio 2023
Risk of cardiovascular diseases associated with medications used in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis
Agosto 2023
Impact of 2018 EU risk minimisation measures and revised pregnancy prevention programme on utilisation and prescribing trends of medicinal products containing valproate: an interrupted time series study
Dicembre 2022
Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure
Dicembre 2022
Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database
Dicembre 2022
SARS-CoV-2 Vaccines and Adverse Effects in Gynecology and Obstetrics: The First Italian Retrospective Study
Settembre 2022
Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination
Settembre 2022
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study

Pagine

80.211.154.110